Loading

ElleVet the heart & science of better pet health

BREAKTHROUGH STUDY PROVES EFFECTIVENESS OF CBD USE IN PETS

ElleVet Sciences is the first company to prove the effectiveness of hemp-based CBD in pets. In a partnership with Cornell University, ElleVet conducted the first clinical trials to test the use of hemp-based products for dogs and the results are astounding.

"This is a game changer that will change the face of veterinary medicine." - Dr. Joseph J. Wakshlag, DVM, PhD
"In our Cornell study, more than 80% of dogs showed significant or dramatic improvement. Seeing people moved to tears by their dogs' return to more happy and active lives confirmed our belief that we can help pets live their best lives." - Amanda Howland, ElleVet Sciences

ElleVet Sciences completed the first-ever clinical trial on dogs with osteoarthritis and partnered with veterinarians at Cornell to publish the first-ever paper on the efficacy of its hemp CBD product in dogs. The results confirmed more than 80% of dogs had significant improvement and those results have been confirmed with thousands of dogs using ElleVet products across the country. It is the first clinical study to prove effectiveness of CBD in pets.

ElleVet is the acknowledged science-driven leader in the hemp CBD field for pets. The company is currently involved in three additional clinical trials in oncology, seizure and post-op pain management and also has studies in IBD and anxiety in the works.

WHAT PEOPLE ARE SAYING ...

MEET OUR EXPERTS

Dr. Joseph Wakshlag, DVM PhD

Joseph J. Wakshlag, DVM, PhD, DACVN, DACVSMR, is a Professor of Nutrition and Sports Medicine at Cornell University School of Veterinary Medicine. In addition to his ground-breaking 2017 study, Dr. Wakshlag and ElleVet are currently conducting seven clinical trials researching the effectiveness in seizure, oncology, acute pain, IBD, atopic dermatitis and anxiety, as well as stomatitis in felines.

Attributed Quotes:

“This will change the face of veterinary medicine for years to come, because we haven’t had a game changer like this in 20 years.”

MICHAEL WILLIAMS

Michael Williams, chairman of ElleVet, is a former Executive Vice President at IDEXX Laboratories, responsible for the International Division and VetLab In-house Diagnostics Business Unit. Dr Williams was at IDEXX for 14 years. Previously he was a healthcare strategy consultant at McKinsey & Company and Senior Research Associate at Scripps Research Institute, California. Dr. Williams holds a Ph.D. in Biochemistry from University of Oxford.

PRESS CONTACT: KELSEY STARKS

502.594.0456

KELSEYKSTARKS@GMAIL.COM